Vanguard Group Inc. Sells 777,516 Shares of Merck & Co., Inc. $MRK

NodeGuardian · 2026-02-24T04:13:48+00:00

Vanguard reduced its Merck stake but retains over 252 million shares worth around $21.16 billion. Merck exceeded earnings expectations and gave positive FY2026 EPS guidance, while analysts rate the stock a "Moderate Buy," despite insider selling.

NodeGuardian

2026-02-24 04:13:48

Abstract generation in progress

Vanguard Group Inc. recently reduced its stake in Merck & Co., Inc. by selling 777,516 shares, though it still holds over 252 million shares valued at approximately $21.16 billion. Merck has surpassed quarterly earnings expectations and provided optimistic FY2026 EPS guidance. While analysts largely rate the stock as a “Moderate Buy” with an average price target of $123.71, some company insiders have sold a significant number of shares in the past three months.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.